These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-001267-63 A PHASE I BRIDGING STUDY USING CH14.18/CHO ANTIBODY IN CHILDREN WITH REFRACTORY NEUROBLASTOMA (NB) 2006-02-01 due-trials
Ongoing 2005-004599-19 INTERFANT 06 not-yet-due
Ongoing 2005-005106-23 Allogeneic stem cell transplantation in children and adolescents with acute lymphoblastic leukemia not-yet-due
Ongoing 2006-001489-17 Anticuerpo monoclonal recombinante antiGDch14.18. Estudio 1 de Neuroblastoma de Alto Riesgo de la SIOP-Europa. Recombination Chimeric Monoclonal Antibody CH.14.18 not-yet-due
Reported results 2006-004710-41 Multizentrische Therapieoptimierungsstudie AML-BFM 2004 zur Behandlung der akuten myeloischen Leukämien bei Kindern und Jugendlichen 2015-10-25 due-trials
Ongoing 2008-000569-50 Allogeneic stem cell transplantation for children and adolescents with CML: Conditioning regimen, donor selection, supportive care and diagnostic procedures not-yet-due
Ongoing 2009-018077-31 A PHASE I/II DOSE SCHEDULE FINDING STUDY not-yet-due
Ongoing 2011-001699-20 International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis not-yet-due
Other 2012-003032-22 Allogenic stem cell transplantation in children and adolescents with acute lymphoblastic leukaemia not-yet-due
Exempt 2013-002492-17 Treatment of adenovirus and cytomegalovirus infection post human allogeneic stem cell transplantation with short-term expanded virus-specific T cells not-yet-due